Supplementary Figure. Nirsevimab Effectiveness Against Medically Attended Respiratory Syncytial Virus Illness and Hospitalization Among Alaska Native Children — Yukon-Kuskokwim Delta Region, Alaska, October 2023–June 2024

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Supplementary Figure. Nirsevimab Effectiveness Against Medically Attended Respiratory Syncytial Virus Illness and Hospitalization Among Alaska Native Children — Yukon-Kuskokwim Delta Region, Alaska, October 2023–June 2024

11/14/2024
By Centers for Disease Control and Prevention (U.S.).
Series: Morbidity and Mortality Weekly Report (MMWR)

[PDF-237.79 KB]

English

Details You May Also Like

Details:

Corporate Authors:

Centers for Disease Control and Prevention (U.S.).
Description:

Supplementary Figure. Morbidity and Mortality Weekly Report, Vol. 73, No. 45, November 14, 2024
Subjects:

[+]

Disease Control Disease Notification Public Health Public Health Surveillance Respiratory Syncytial Virus Infections / Prevention & Control
Series:

Morbidity and Mortality Weekly Report (MMWR)
Document Type:

Journal article
Genre:

Tables ; Statistics

Tables ; Statistics Less -
Place as Subject:

United States
Volume:

73
Issue:

45
Collection(s):

Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:

[+]

urn:sha-512:e8c3e01b8f7dd111d0347beaf955cd04ae53c65c9f7fbf8aef8e9f9291bbc1b627fad020a672284b676122d55c158bd8e149394b3a4c5134889ed0c219ccc295
Download URL:

https://stacks.cdc.gov/view/cdc/168889/cdc_168889_DS1.pdf
File Type:

No Additional Files

More +

Supplementary Figure. Nirsevimab Effectiveness Against Medically Attended Respiratory Syncytial Virus Illness and Hospitalization Among Alaska Native Children — Yukon-Kuskokwim Delta Region, Alaska, October 2023–June 2024

Details:

Supporting Files

You May Also Like